# BIO-key International Q3 2026 Earnings Miss

> BIO-key International's Q3 2026 earnings miss hides operational progress as stock rises.
- Title: BIO-key International Q3 2026 Earnings Miss | Shortify
- Summary: BIO-key International's Q3 2026 earnings miss hides operational progress as stock rises.
- Keywords: bio-key international, bkyi, earnings analysis, inc, q3 2026, software licensing, revenue composition, gross margin, license fee revenue, emesa segment, middle east customers, q1 2027
- URL: https://shortify.news/story/bio-key-international-q3-2026-earnings-miss
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/bio-key-international-q3-2026-earnings-deep-dive-key-takeaways
- Author: AlphaStreet Newsdesk
- Published: 2026-11-13T17:54:02+00:00
- Read time: 1 min
- Topics: bio-key international, bkyi, earnings analysis, inc, q3 2026, software licensing, revenue composition, gross margin, license fee revenue, emesa segment, middle east customers, q1 2027
## Q3 2026 Earnings Results
BIO-key International reported an EPS loss of $4.01 per share in Q3 2026, missing analyst estimates of a $0.35 loss.
## Revenue and Stock Performance
Revenue fell to $1.5M from $2.4M estimates, but stock rose 4.0% to $2.58.
## Margin Expansion Story
Gross margin expanded to 89.3% from 77% a year ago, driven by software license revenue growth.

> license fee revenue grew 39% year over year, and that high-margin recurring revenue lifted our gross margin to 90%, from 77% a year ago and helped reduce our operating loss by 8%
## Revenue Composition Shift
Software license fee revenue grew 39.0%, offsetting lower hardware sales despite a 4.3% year-over-year revenue decline.
## Sequential Deterioration
Revenue declined from $2.1M in Q1 2026 to $1.5M in Q3 2026, with EPS collapsing from $0.15 to $4.01 loss.
## Q1 2027 Inflection Point
Management targets profitability by Q1 2027 with $1.2 million in annual license fee renewals.

> We expect roughly $1.2 million in annual license fee renewals in the first quarter alone, and we are targeting profitability as we approach that timeframe
## Market Reaction
Stock rose 4.0% despite earnings miss, signaling investor confidence in margin improvements and Q1 2027 renewal cycle.
## Key takeaway

BIO-key International reported a $4.01 per share loss in Q3 2026, missing analyst estimates, but stock rose 4.0% to $2.58 as investors saw margin improvements from software licensing.

---

Summary: Shortify — https://shortify.news/story/bio-key-international-q3-2026-earnings-miss
Reporting: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/bio-key-international-q3-2026-earnings-deep-dive-key-takeaways

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.